| Health outcomes and economic burden of hospitalized COVID-19 patients in the United States M Di Fusco, KM Shea, J Lin, JL Nguyen, FJ Angulo, M Benigno, ... Journal of Medical Economics 24 (1), 308-317, 2021 | 182 | 2021 |
| COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies M Di Fusco, J Lin, S Vaghela, M Lingohr-Smith, JL Nguyen, ... Expert Review of Vaccines 21 (4), 435-451, 2022 | 62 | 2022 |
| Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients S Deitelzweig, A Keshishian, X Li, A Kang, AD Dhamane, X Luo, ... Journal of the American Geriatrics Society 67 (8), 1662-1671, 2019 | 61 | 2019 |
| Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study GYH Lip, AV Keshishian, AL Kang, AD Dhamane, X Luo, X Li, ... Journal of internal medicine 289 (1), 42-52, 2021 | 50 | 2021 |
| Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2 M Di Fusco, MM Moran, A Cane, D Curcio, F Khan, D Malhotra, ... Journal of Medical Economics 24 (1), 1248-1260, 2021 | 43 | 2021 |
| Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure A Amin, AB Garcia Reeves, X Li, A Dhamane, X Luo, M Di Fusco, ... PLoS One 14 (3), e0213614, 2019 | 41 | 2019 |
| Effectiveness and safety of oral anticoagulants among NVAF patients with obesity: insights from the ARISTOPHANES study S Deitelzweig, A Keshishian, A Kang, AD Dhamane, X Luo, X Li, ... Journal of Clinical Medicine 9 (6), 1633, 2020 | 35 | 2020 |
| Anticoagulation therapy in patients with non-valvular atrial fibrillation in a private setting in Brazil: a real-world study PGMB Silva, H Sznejder, R Vasconcellos, GM Charles, ... Arquivos Brasileiros de Cardiologia 114 (3), 457-466, 2020 | 26 | 2020 |
| Effectiveness and safety of oral anticoagulants in patients with nonvalvular atrial fibrillation and diabetes mellitus GYH Lip, AV Keshishian, AL Kang, X Li, AD Dhamane, X Luo, ... Mayo Clinic Proceedings 95 (5), 929-943, 2020 | 23 | 2020 |
| Effectiveness and safety of anticoagulants in adults with non-valvular atrial fibrillation and concomitant coronary/peripheral artery disease RD Lopes, J Steffel, M Di Fusco, A Keshishian, X Luo, X Li, C Masseria, ... The American Journal of Medicine 131 (9), 1075-1085. e4, 2018 | 21 | 2018 |
| Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data J Yang, S Vaghela, B Yarnoff, S De Boisvilliers, M Di Fusco, TL Wiemken, ... Expert Review of Vaccines 22 (1), 54-65, 2023 | 16 | 2023 |
| The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths TK Yamana, M Galanti, S Pei, M Di Fusco, FJ Angulo, MM Moran, F Khan, ... Plos one 18 (4), e0275699, 2023 | 15 | 2023 |
| Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States M Di Fusco, K Marczell, KA Deger, MM Moran, TL Wiemken, A Cane, ... Journal of Medical Economics 25 (1), 605-617, 2022 | 15 | 2022 |
| Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients M Di Fusco, X Sun, MM Moran, H Coetzer, JM Zamparo, L Puzniak, ... Journal of Patient-Reported Outcomes 6 (1), 123, 2022 | 15 | 2022 |
| Non-persistence to oral anticoagulation treatment in patients with non-valvular atrial fibrillation in the USA AD Dhamane, I Hernandez, M Di Fusco, C Gutierrez, M Ferri, C Russ, ... American Journal of Cardiovascular Drugs, 1-11, 2022 | 14 | 2022 |
| Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis S Deitelzweig, E Bergrath, M di Fusco, A Kang, M Savone, JC Cappelleri, ... Future Cardiology 18 (5), 393-405, 2022 | 14 | 2022 |
| The burden of undertreatment and non-treatment among patients with non-valvular atrial fibrillation and elevated stroke risk: a systematic review M Sussman, GD Barnes, JD Guo, CY Tao, JA Gillespie, M Ferri, N Adair, ... Current Medical Research and Opinion 38 (1), 7-18, 2022 | 14 | 2022 |
| Profiling clinical characteristics and treatment patterns among non-valvular atrial fibrillation patients: a real-world analysis in Dubai, United Arab Emirates M El Kadri, N Bazargani, M Farghaly, R Mohamed, N Awad, A Natarajan, ... Open Medicine Journal 6 (1), 2019 | 12 | 2019 |
| COVID-19-associated hospitalizations among children less than 12 years of age in the United States M Di Fusco, S Vaghela, MM Moran, J Lin, JE Atwell, D Malhotra, ... Journal of Medical Economics 25 (1), 334-346, 2022 | 11 | 2022 |
| Effectiveness and safety of Apixaban versus warfarin in obese patients with Nonvalvular atrial fibrillation enrolled in Medicare and veteran affairs S Deitelzweig, J Sah, A Kang, C Russ, M Preib, AD Dhamane, A Ratiu, ... The American Journal of Cardiology 163, 43-49, 2022 | 11 | 2022 |
